• News
  • Lifestyle
    • Recipes
    • Video
    • Lotto Results
    • Technology
  • Entertainment
  • Travel
  • Sport
  • Expat Life
  • Move to Australia
Sunday, January 24, 2021
Australian Times News
  • News
  • Lifestyle
    • Recipes
    • Video
    • Lotto Results
    • Technology
  • Entertainment
  • Travel
  • Sport
  • Expat Life
  • Move to Australia
No Result
View All Result
  • News
  • Lifestyle
    • Recipes
    • Video
    • Lotto Results
    • Technology
  • Entertainment
  • Travel
  • Sport
  • Expat Life
  • Move to Australia
No Result
View All Result
Australian Times News
No Result
View All Result
Home News

COVID-19 vaccines were developed in record time – but are these game-changers safe?

There are now two COVID-19 vaccines that, at least according to preliminary reports, appear to be 94.5% and 95% effective. Both were developed in a record-breaking 11 months or so.

The Conversation by The Conversation
21-11-2020 18:05
in News
COVID-19 vaccines

COVID-19 vaccines Photo by Medakit Ltd on Unsplash

William Petri, University of Virginia

There are now two COVID-19 vaccines that, at least according to preliminary reports, appear to be 94.5% and 95% effective. Both were developed in a record-breaking 11 months or so.

The pandemic rages as the world waits for COVID-19 vaccines. Peter Zelei Images/Getty Images

I am an infectious diseases specialist and professor at the University of Virginia. I care for patients with COVID-19 and am conducting the local site for a phase 3 clinical trial of Regeneron’s antibody cocktail as a tool to prevent household transmission of COVID-19. I’m also conducting research on how dysregulation of the immune system during SARS-CoV-2 infection causes lung damage.

Despite the vaccines’ relatively rapid development, the normal safety testing protocols are still in place.

How long does most vaccine development take?

Vaccines typically take at least a decade to develop, test and manufacture. Both the chickenpox vaccine and FluMist, which protects against several strains of the influenza virus, took 28 years to develop. It took 15 years to develop a vaccine for human papilloma virus, which can cause six kinds of cancer. It also took 15 years to develop a vaccine for rotavirus, which commonly causes severe, watery diarrhea. It took Jonas Salk six years to develop and test the first polio vaccine, starting with the isolation of the virus.

The Pfizer-BioNTech and the Moderna COVID-19 messenger RNA vaccines, by contrast, have been developed in less than a year. That’s a game-changer.

How was this vaccine developed so quickly?

The mRNA vaccines produced by Pfizer and Moderna are faster to develop as they do not require companies to produce protein or weakened pathogen for the vaccine.

AlsoRead...

Environmental impact

Pollinators: neonicotinoid pesticides stop bees and flies from getting a good night’s sleep

24 January 2021
Players risk losing fitness

Self-entitled prima donnas or do they have a point? Why Australian Open tennis players find hard lockdown so tough

24 January 2021
The spike proteins (red) on the surface of SARS-CoV-2, the virus that causes COVID-19, are essential for infecting human cells. Viktoriia Ilina/iStock/Getty Images Plus

Traditional vaccines typically use a weakened version of the pathogen or a protein piece of it, but because these are grown in eggs or cells, developing and manufacturing vaccines takes a long time. By contrast, by using just the genetic material that makes the Spike glycoprotein – the protein on the surface of the coronavirus that is essential for infecting human cells – the design and manufacture of the vaccine is simplified.

The genetic material mRNA is easy to make in a laboratory. Manufacturing an mRNA vaccine rather than a protein vaccine can save months, if not years.

Another factor that accelerated vaccine development was the swift and efficient recruitment of patients for clinical trials.

How is safety assured when vaccine development is so fast?

Safety is the first and foremost goal for a vaccine.

In my opinion, safety is not compromised by the speed of vaccine development and emergency use authorization. The reason that vaccines may be approved so quickly is that the large clinical trials to assess vaccine efficacy and safety are happening at the same time as the large-scale manufacturing preparation, funded by the federal government’s Operation Warp Speed program.

Typically, large-scale manufacturing begins only once the vaccine has been tested in clinical trials. In the case of COVID-19, the U.S. government wanted to be ready to begin distributing the vaccine the moment the results of the phase 3 trials were known and the safety data had been analyzed.

To this end, the pharmaceutical companies launched at-risk manufacturing – which means that the manufactured vaccine doses would be thrown away if the vaccine was ineffective or unsafe – during the FDA-mandated two-month safety waiting period.

The upside is that if the vaccine is safe and effective, it can be distributed immediately, and vaccination can begin.

Are these vaccines riskier than others?

No mRNA vaccines have been approved before because it is relatively new technology.

But these mRNA vaccines appear safe and no riskier than other tried and tested ones, like the childhood measles vaccine. To date, no significant side effects have been reported in the interim phase 3 studies of the Moderna and Pfizer vaccines.

[Deep knowledge, daily. Sign up for The Conversation’s newsletter.]

Side effects that have been reported are minor things that one would expect with any vaccine, including soreness at the site of injection and transient fatigue, muscle or joint aches.

How will EUA work?

EUA stands for emergency use authorization.

Under EUA, the FDA is requiring that a COVID-19 vaccine be at least 50% effective at preventing symptomatic illness.

It is also requiring a median of two months of follow-up after completion of the vaccination for half of the vaccine recipients (for most of the vaccines this is two doses). This two-month period is to allow detection of an adverse event from the vaccine.

William Petri, Professor of Medicine, University of Virginia

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Tags: SB001
DMCA.com Protection Status

SUBSCRIBE to our NEWSLETTER

Terms and Conditions

CURRENCY ZONE

Australian Forex

Don't Miss

Pollinators: neonicotinoid pesticides stop bees and flies from getting a good night’s sleep

by The Conversation
24 January 2021
Environmental impact
News

Neonicotinoids, the most commonly used pesticides in the world, were banned in the EU in 2018. More than 99,000 people...

Read more

Self-entitled prima donnas or do they have a point? Why Australian Open tennis players find hard lockdown so tough

by The Conversation
24 January 2021
Players risk losing fitness
News

The challenge of bringing the world’s best tennis players and support staff, about 1,200 people in all, from COVID-ravaged parts...

Read more

Why the COVID-19 variants are so dangerous and how to stop them spreading

by The Conversation
24 January 2021
COVID-19 variants
News

Changes in the genetic code of viruses like COVID-19 occur all the time but most of these mutations don’t have...

Read more

Gulf blockade: Qatar hugs and makes up with its warring neighbours – but will it last?

by The Conversation
24 January 2021
Gulf blockade
News

Qatar may be the smallest of the Gulf states – but it’s the richest. So when, hours after the agreement,...

Read more

Davos 2021: to achieve a ‘great reset’, we can’t count on the same old globalists to lead the way

by The Conversation
23 January 2021
The great reset
News

The 51st World Economic Forum starts on January 25, but with a major difference. Whereas this is famously the annual...

Read more

Gene-edited crops are now a reality – but will the public be on board?

by The Conversation
23 January 2021
Gene-edited crops
News

Whereas GM crops typically contain the DNA of two different species, gene editing is more precise and allows scientists to...

Read more

Lotto Results for Saturday, 23 January 2021

by Sonja Baartman
23 January 2021
Lottery Results Lotto Numbers UK
UK Lotto

Are you ready for the National Lottery Lotto draw? Let's find out if you're an overnight millionaire

Read more
Load More

Copyright © Blue Sky Publications Ltd. All Rights Reserved.
australiantimes.co.uk is a division of Blue Sky Publications Ltd. Reproduction without permission prohibited. DMCA.com Protection Status

  • About us
  • Write for Us
  • Advertise
  • Contact us
  • T&Cs, Privacy and GDPR
No Result
View All Result
  • News
  • Lifestyle
    • Recipes
    • Video
    • Lotto Results
    • Technology
  • Entertainment
  • Travel
  • Sport
  • Expat Life
  • Move to Australia

Copyright © Blue Sky Publications Ltd. All Rights Reserved.
australiantimes.co.uk is a division of Blue Sky Publications Ltd. Reproduction without permission prohibited. DMCA.com Protection Status